Adjunctive risperidone treatment in patients with 'clozapine-resistant schizophrenia'

被引:22
作者
Adesanya, A [1 ]
Pantelis, C
机构
[1] Mental Hlth Res Inst Victoria, Appl Schizophrenia Div, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Psychiat, Cognit Neuropsychiat Unit, Melbourne, Vic, Australia
[3] Sunshine Hosp, Melbourne, Vic, Australia
关键词
D O I
10.1080/j.1440-1614.2000.0751j.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:533 / 534
页数:2
相关论文
共 8 条
[1]  
Henderson DC, 1996, J CLIN PSYCHIAT, V57, P395
[2]   TREATMENT OF SCHIZOPHRENIA [J].
KANE, JM ;
MCGLASHAN, TH .
LANCET, 1995, 346 (8978) :820-825
[3]   RISPERIDONE AUGMENTATION OF CLOZAPINE [J].
MCCARTHY, RH ;
TERKELSEN, KG .
PHARMACOPSYCHIATRY, 1995, 28 (02) :61-63
[4]   Risperidone and clozapine combination for the treatment of refractory schizophrenia [J].
Morera, AL ;
Barreiro, P ;
Cano-Muñoz, JL .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 99 (04) :305-306
[5]   Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients [J].
Nyberg, S ;
Eriksson, B ;
Oxenstierna, G ;
Halldin, C ;
Farde, L .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06) :869-875
[6]  
OWENS MJ, 1995, TXB PSYCHOPHARMACOLO, P263
[7]   Drug strategies and treatment-resistant schizophrenia [J].
Pantelis, C ;
Barnes, TRE .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1996, 30 (01) :20-37
[8]  
PEACOCK L, 1994, J CLIN PSYCHIAT, V55, P44